110 related articles for article (PubMed ID: 20637607)
1. 3-D-QSAR and docking studies on the neuronal choline transporter.
Geldenhuys WJ; Allen DD; Lockman PR
Bioorg Med Chem Lett; 2010 Aug; 20(16):4870-7. PubMed ID: 20637607
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; McAfee JH; Fitzpatrick KT; Van der Schyf CJ; Allen DD
Bioorg Med Chem Lett; 2004 Jun; 14(12):3085-92. PubMed ID: 15149650
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
[TBL] [Abstract][Full Text] [Related]
5. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
6. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Yi P; Fang X; Qiu M
Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
[TBL] [Abstract][Full Text] [Related]
8. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.
Srivani P; Sastry GN
J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
11. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
Ravindra GK; Achaiah G; Sastry GN
Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
[TBL] [Abstract][Full Text] [Related]
13. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
Zeng H; Cao R; Zhang H
Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
[TBL] [Abstract][Full Text] [Related]
14. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
Yuan H; Kozikowski AP; Petukhov PA
J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
Indarte M; Madura JD; Surratt CK
Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
[TBL] [Abstract][Full Text] [Related]
17. Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFalpha modulators.
Avila CM; Romeiro NC; da Silva GM; Sant'Anna CM; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2006 Oct; 14(20):6874-85. PubMed ID: 16843662
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors.
Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK
J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201
[TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
20. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
